Tamar Thompson is Director of CATALYST PHARMACEUTICALS, INC.. Currently has a direct ownership of 1,413 shares of CPRX, which is worth approximately $30,549. The most recent transaction as insider was on Dec 09, 2024, when has been sold 1,413 shares (Common Stock, par value $0.001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.41K
n/a 3M change
n/a 12M change
Total Value Held $30,549

Tamar Thompson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 09 2024
BUY
Exercise of conversion of derivative security
-
1,413 Added 50.0%
1,413 Common Stock, par valu...

Also insider at

RNA
Avidity Biosciences, Inc. Healthcare
TT

Tamar Thompson

Director
San Diego, CA

Track Institutional and Insider Activities on CPRX

Follow CATALYST PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CPRX shares.

Notify only if

Insider Trading

Get notified when an Catalyst Pharmaceuticals, Inc. insider buys or sells CPRX shares.

Notify only if

News

Receive news related to CATALYST PHARMACEUTICALS, INC.

Track Activities on CPRX